"OMRON receives FDA authorisation for blood pressure monitors with AFib feature" was originally created and published by ...
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...